Svetlana Mojsov, a researcher at Rockefeller University whose work has been important in the characterization of GLP-1 and clarification of its role in glucose metabolism, explained in an interview with PNAS this September, Once we solve obesity, I think a lot of other disorders will be taken care of As for all the other pathophysiological states in which GLP-1-based drugs appear to be beneficial, I think it may have something to do with the drugs central role in regulating glucose metabolism. But lowering glucose isnt GLP-1s only job, though as Mojsov said, the relationship with glucose metabolism may be a crucial central part in the many related conditions it seems to treat
Here are my disclosures, which are basically lecture fees and participation in some scientific groups
Semaglutide vs Tirzepatide In the world of GLP-1 weight loss drugs, two names stand out: semaglutide and tirzepatide
Imaging 14 , e012174 (2021)
Recent studies using pFUS targeting the porta hepatis demonstrated significant metabolic improvements in mouse models of obesity
Personalizing eye color might sound tempting, especially for younger people and those who enjoy experimenting with elements of fashion or style